Piclofenac potassium sustained release capsule and preparing technique thereof

A technology of diclofenac potassium and sustained-release capsules, applied in the field of medicine, can solve the problems of unstable blood drug concentration, inconvenience to patients, toxic and side effects, etc., and achieve the effects of excellent release curve, reduced administration times, and low production cost.

Inactive Publication Date: 2010-10-13
海南华旗药业销售有限公司
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Diclofenac potassium is currently available in the domestic market in the form of tablets and capsules, and its usage and dosage are: 100-150mg / day (2-3 capsules / day) for adults, up to 200mg / day (4 capsules / day) for severe cases. The frequent medication brings great inconvenience to the patients, and the blood drug concentration is not stable, and the peak-valley phenomenon occurs, and the high-dose medication produces great toxic and side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Piclofenac potassium sustained release capsule and preparing technique thereof
  • Piclofenac potassium sustained release capsule and preparing technique thereof
  • Piclofenac potassium sustained release capsule and preparing technique thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] Embodiment 1 Diclofenac Potassium Sustained Release Capsules

[0047] Diclofenac Potassium 100mg

[0048] Blank pellet core 300mg

[0049] Starch 33mg

[0050] Ethylcellulose 96mg

[0051] Macrogol 6000 8mg

[0052] Talc powder 15mg

[0053] Titanium Dioxide 3mg

[0054] The preparation steps are:

[0055] (1) Add 300g of blank pellet cores to the granulator, spray an appropriate amount of ethanol for wetting, add a mixture of 100g of diclofenac potassium and 33g of starch, and process for 30 minutes to make drug-containing pellets with smooth surfaces;

[0056] (2) Dissolve 96g of ethylcellulose and 8g of polyethylene glycol 6000, 15g of talcum powder, and 3g of titanium dioxide with 95% ethanol solution to make a slow-release coating solution;

[0057] (3) Evenly spray the prepared sustained-release coating solution on the surface of the prepared drug-containing pellets, and then place the obtained sustained-release pellets in a vacuum oven at 70°C for 2 hours ...

Embodiment 2

[0059] Embodiment 2 Diclofenac Potassium Sustained Release Capsules

[0060] Diclofenac Potassium 100mg

[0061] Blank pellet core 300mg

[0062] Hypromellose 10mg

[0063] Talc powder 15mg

[0064] Acrylic resin 120mg

[0065] Glycerin 13mg

[0066] Micronized silica gel 15mg

[0067] Titanium Dioxide 3mg

[0068] The preparation steps are:

[0069] (1) Dissolve 100g diclofenac potassium, 10g hypromellose, and 15g talcum powder with 70% ethanol solution to make a coating suspension;

[0070] (2) Add 300g of blank pellet cores to the granulator, spray the prepared coating suspension on the surface of the blank pellet cores, and then vacuum-dry at 45°C to obtain drug-containing pellets;

[0071] (3) Dissolve 120g of acrylic resin and 13g of glycerin, 15g of micropowdered silica gel, and 3g of titanium dioxide with 40-80% ethanol solution to make a slow-release coating solution;

[0072] (4) Evenly spray the prepared sustained-release coating solution on the surface of ...

Embodiment 3

[0074] Example 3 Diclofenac Potassium Sustained Release Capsules

[0075] Diclofenac Potassium 200mg

[0076] Blank pellet core 300mg

[0077] Lactose 45mg

[0078] Microcrystalline Cellulose 37mg

[0079] Cellulose acetate 132mg

[0080] Povidone 21mg

[0081] Triethyl Citrate 22mg

[0082] Talc 34mg

[0083] The preparation steps are:

[0084] (1) Add 300g of blank ball cores to the granulator, spray an appropriate amount of 80% ethanol solution for wetting, add a mixture of 200g of diclofenac potassium, 45g of lactose, and 37g of microcrystalline cellulose, and place for 90 minutes to make a drug-containing pellet with a smooth surface. pellets;

[0085] (2) Dissolve 153g cellulose acetate, 22g triethyl citrate, 21g povidone, 34g talcum powder with 60%~95% ethanol solution to make slow-release coating liquid;

[0086] (3) Evenly spray the prepared sustained-release coating solution on the surface of the prepared drug-containing pellets, and then place the obtained ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a diclofenac potassium sustained-release capsule which is anti-inflammation and analgesic drug, and a production method thereof. The diclofenac potassium sustained-release capsule is formed by preparing diclofenac potassium into sustained-release pellets and then filling the pellets into the capsule; the diclofenac potassium sustained-release pellet consists of a blank pellet core taken as mother nucleus, a main drug layer which is coated outside of the pellet core and contains diclofenac potassium and a sustained-release coating layer covered on the main drug layer. The diclofenac potassium sustained-release capsule of the invention has fine preparation stability and prominent release effect.

Description

technical field [0001] The invention relates to a sustained-release preparation, in particular to a diclofenac potassium sustained-release capsule and a production method thereof, belonging to the technical field of medicine. Background technique [0002] Diclofenac potassium is a non-steroidal anti-inflammatory drug, and its active ingredient is diclofenac, which mainly produces analgesic, anti-inflammatory and antipyretic effects by inhibiting the synthesis of prostaglandins. It has a good therapeutic effect on joint pain caused by rheumatoid arthritis, rheumatoid arthritis, degenerative osteoarthritis, gout, soft tissue inflammation around the joint, and injury. Its curative effect is better than other steroidal drugs such as indomethacin, aspirin, fenbid, naproxen, etc., and it is absorbed quickly, has fewer side effects, and has lighter gastrointestinal reactions than most non-steroidal anti-inflammatory drugs, and is well tolerated. Small and individual differences ar...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/28A61K9/48A61K31/196A61P29/00
Inventor 邱民
Owner 海南华旗药业销售有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap